NEW YORK (GenomeWeb news) – Olink Bioscience said today that it has signed up Immuno Diagnostic to distribute its in situ protein detection systems in Finland.
Under the agreement, the Finnish company Immuno Diagnostic will distribute the Duolink in situ PLA product line, which is a proximity ligation assay technology that is used to detect proteins and their interactions and modifications. The technology allows for detection of target proteins with single-molecule resolution, Uppsala, Sweden-based Olink said.
"We see a great potential market for the PLA technology in the areas of academic and industrial research in Finland," Immuno Diagnostic's Sales Director and VP, Marko Laine, said in a statement.
Financial terms of the agreement were not released.